Oral anticoagulant therapy in the chronic phase of myocardial infarction

P. Smith

Research output: Contribution to journalArticlepeer-review


A causal role of coronary thrombosis in evolving myocardial infarction is now widely accepted. Patients recovering from an acute heart attack have a higher risk of dying, or suffering another infarction, than an age-matched noncoronary population. Thrombosis plays a major part in this additional mortality and morbidity. The use of oral anticoagulants in the secondary prophylaxis of acute myocardial infarction is controversial. This article reviews the role of oral anticoagulant drugs in the prevention of secondary events in patients who have survived a heart attack.

Original languageEnglish
Pages (from-to)97-101
Number of pages5
JournalArchives of Pathology and Laboratory Medicine
Issue number1
StatePublished - 1993
Externally publishedYes


Dive into the research topics of 'Oral anticoagulant therapy in the chronic phase of myocardial infarction'. Together they form a unique fingerprint.

Cite this